DiBiCol® - development of a multigene diagnostic test for the differentiation ofinflammatory bowel disease subtypes

European Gastroenterology and Hepatology Review

Volumn 8, Issue 1, 2012, Pages 40-43

  Gielen, Alexander W ^a   Sundell, Therese ^a   von Stein, Petra ^a  

^a InDex Pharmaceuticals AB   (Sweden)

Author keywords

Colonoscopy; Crohn's disease; DiBiCol ; IBD unclassified; Indeterminate colitis; InDex Pharmaceuticals AB; Inflammatory bowel disease (IBD); Irritable bowel syndrome; Quantitative polymerase chain reaction diagnostics; Ulcerative colitis

Indexed keywords

BIOLOGICAL MARKER; COMPLEMENTARY DNA;

ARTICLE; COLON BIOPSY; CROHN DISEASE; DIAGNOSTIC ACCURACY; DIAGNOSTIC APPROACH ROUTE; DIAGNOSTIC KIT; DIAGNOSTIC TEST; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; DISEASE CLASSIFICATION; DNA DETERMINATION; ENTERITIS; GENE; GENE EXPRESSION; GENE IDENTIFICATION; GROWTH RELATED ONCOGENE ALPHA GENE; HUMAN; MATRIX METALLOPROTEINASE 7 GENE; POLYMERASE CHAIN REACTION; REGENERATING PROTEIN IV GENE; RNA EXTRACTION; SMALL PROTEIN ASSOCIATED WITH PDZ DOMAIN CONTAINING PROTEIN 1 GENE; SOLUTE CARRIER 26A2 GENE; SOLUTE CARRIER 6A14 GENE; ULCERATIVE COLITIS; VANIN 1 GENE;

EID: 84875268604     PISSN: 17583799     EISSN: 17583802     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Ekbom A, The epidemiology of IBD: a lot of data but little knowledge. How shall we proceed?, Inflamm Bowel Dis, 2004;10(Suppl. 1):S32-4.
2. Shivananda S, Lennard-Jones J, Logan R, et al., Incidence of inflammatory bowel disease across Europe: is there a difference between north and south? Results of the European Collaborative Study on Inflammatory Bowel Disease (EC-IBD), Gut, 1996;39:690-7.
3. Schirbel A, Fiocchi C, Inflammatory bowel disease: Established and evolving considerations on its etiopathogenesis and therapy, J Dig Dis, 2010;11:266-76.
4. Strober WF, Blumberg RS, The immunology of mucosal models of inflammation, Annu Rev Immunol, 2002;20:495-549.
5. Annunziato FC, Cosmi L, Santarlasci V, et al., Phenotypic and functional features of human Th17 cells, J Exp Med, 2007;204:1849-61.
6. Fuss IJ, Heller F, Borivant M, et al., Non-classical CD1d-restricted NK T cells that produce IL-13 characterize an atypical Th2 response in ulcerative colitis, J Clin Invest, 2004;113:1490-7.
7. McFarland L, State-of-the-art of irritable bowel syndrome and inflammatory bowel disease research in 2008, World J Gastroenterol, 2008;14:2625-9.
8. Bentley EJ, Jenkins D, Campbell F, et al., How could pathologists improve the initial diagnosis of colitis? Evidence from an international workshop, J Clin Pathol, 2002;55:955-60.
9. Geboes KC, Colombel JF, Greenstein A, et al., Indeterminate colitis: a review of the concept - what's in a name?, Inflamm Bowel Dis, 2008;14:850-7.
10. Satsangi JS, Silverberg MS, Vermeire S, Colombel JF, The Montreal classification of inflammatory bowel disease: controversies, consensus, and implications, Gut, 2006;55:749-53.
11. Martland GT, Shepherd NA, indeterminate colitis: definition, diagnosis, implications and a plea for nosological sanity, Histopathology, 2007;50:83-96.
12. Meucci G, What is the incidence, prevalence, and natural history of indeterminate colitis?, Inflamm Bowel Dis, 2008;14:S159-60.
13. Nikolaus S, Schreiber S, Diagnostics of inflammatory bowel disease, Gastroenterology, 2007;133:1670-89.
14. Desai D, Faubion WA, Sandborn WJ, Review article: biological activity markers in inflammatory bowel disease, Aliment Pharmacol Ther, 2007;25:247-55.
15. Langhorst J, Elsenbruch S, Koelzer J, et al., Noninvasive markers in the assessment of intestinal inflammation in inflammatory bowel diseases: performance of fecal lactoferrin, calprotectin, and PMN-elastase, CRP, and clinical indices, Am J Gastroenterol, 2008;103:162-9.
16. Peyrin-Biroulet L, Standaert-Vitse A, Branche J, Chamaillard M, IBD serological panels: facts and perspectives, Inflamm Bowel Dis, 2007;13:1561-6.
17. Papp M, Norman GL, Altorjay I, Lakatos PL, Utility of serological markers in inflammatory bowel diseases: gadget or magic?, World J Gastroenterol, 2007;13:2028-36.
18. Meuwis MA, Fillet M, Chapelle JP, et al., New biomarkers of Crohn's disease: serum biomarkers and development of diagnostic tools, Expert Rev Mol Diagn, 2008;8:327-37.
19. Lewis JD, The utility of biomarkers in the diagnosis and therapy of inflammatory bowel disease, Gastroenterology, 2011;140:1817-26 e2.
20. Von Stein OD, Isolation of differentially expressed genes through subtractive suppression hybridization, Methods Mol Biol, 2001;175:263-78.
21. Von Stein PL, Lofberg R, Kuznetsov NV, et al., Multigene analysis can discriminate ulcerative colitis, Crohn's disease and irritable bowel syndrome, Gastroenterol, 2008;134:1869-81.